Tech Company Financing Transactions

Silk Road Medical Funding Round

On 7/19/2017, Silk Road Medical raised $47 million in funding from Norwest Venture Partners, CRG and Janus Capital.

Transaction Overview

Company Name
Silk Road Medical
Announced On
7/19/2017
Transaction Type
Venture Equity
Amount
$47,000,000
Round
Undisclosed
Investors

Norwest Venture Partners (Lead Investor) (Robert Mittendorff)

CRG

Janus Capital

The Vertical Group

Warburg Pincus (Bess Weatherman)

Proceeds Purpose
The new financing will be used to support the company's rapid commercial growth of its proprietary ENROUTE family of products for TransCarotid Artery Revascularization (TCAR) procedures.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1213 Innsbruck Dr.
Sunnyvale, CA 94089
USA
Phone
(408) 720-9002
Website
www.silkroadmed.com
Email Address
[email protected]
Overview
Silk Road Medical, Inc. is a company that develops and manufactures less-invasive medical devices intended to improve the treatment of carotid artery disease through proprietary transcarotid therapies.
Profile
Silk Road Medical LinkedIn Company Profile
Social Media
Silk Road Medical Company Twitter Account
Company News
Silk Road Medical News
Facebook
Silk Road Medical on Facebook
YouTube
Silk Road Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Erica Rogers
  Erica Rogers LinkedIn Profile  Erica Rogers Twitter Account  Erica Rogers News  Erica Rogers on Facebook
Chief Financial Officer
Lucas Buchanan
  Lucas Buchanan LinkedIn Profile  Lucas Buchanan Twitter Account  Lucas Buchanan News  Lucas Buchanan on Facebook
Chief Medical Officer
Sumaira Macdonald
  Sumaira Macdonald LinkedIn Profile  Sumaira Macdonald Twitter Account  Sumaira Macdonald News  Sumaira Macdonald on Facebook
VP - Finance
Mhairi Jones
  Mhairi Jones LinkedIn Profile  Mhairi Jones Twitter Account  Mhairi Jones News  Mhairi Jones on Facebook
VP - Human Resources
Alison Highlander
  Alison Highlander LinkedIn Profile  Alison Highlander Twitter Account  Alison Highlander News  Alison Highlander on Facebook
VP - Marketing
Mark Page
  Mark Page LinkedIn Profile  Mark Page Twitter Account  Mark Page News  Mark Page on Facebook
VP - Operations
Robert Nicholas
  Robert Nicholas LinkedIn Profile  Robert Nicholas Twitter Account  Robert Nicholas News  Robert Nicholas on Facebook
VP - Operations
Frances Versprille
  Frances Versprille LinkedIn Profile  Frances Versprille Twitter Account  Frances Versprille News  Frances Versprille on Facebook
VP - Regulatory Affairs
Tammy Leitsinger
  Tammy Leitsinger LinkedIn Profile  Tammy Leitsinger Twitter Account  Tammy Leitsinger News  Tammy Leitsinger on Facebook
VP - Regulatory Affairs
Richard Ruedy
  Richard Ruedy LinkedIn Profile  Richard Ruedy Twitter Account  Richard Ruedy News  Richard Ruedy on Facebook
VP - Sales
Andrew Davis
  Andrew Davis LinkedIn Profile  Andrew Davis Twitter Account  Andrew Davis News  Andrew Davis on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/19/2017: InSilico Medicine venture capital transaction
Next: 7/19/2017: Embark Veterinary venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.